Montelukast versus fluticasone: effects on lung function, airway responsiveness and inflammation in moderate asthma Source: Eur Respir J 2002; 20: 853-858 Year: 2002
Effect of formoterol with or without budesonide in repeated low-dose allergen challenge Source: Eur Respir J 2009; 33: 747-753 Year: 2009
Inhaled synthetic surfactant abolishes the early allergen-induced response in asthma Source: Eur Respir J 2003; 21: 1046-1049 Year: 2003
Effects of roflumilast on exhaled NO, airway hyperresponsiveness, and inflammatory markers in patients with asthma Source: Eur Respir J 2006; 28: Suppl. 50, 670s Year: 2006
Effect of montelukast added to inhaled corticosteroids on fractional exhaled nitric oxide in asthmatic children Source: Eur Respir J 2002; 20: 630-634 Year: 2002
Benefit of inhaled corticosteroids (ICS) in asthmatic patients with bronchial hyperresponsiveness (BHR) to mannitol and low fractional exhaled nitric oxide (FeNO) levels Source: International Congress 2017 – Monitoring asthma control Year: 2017
Markers of airway inflammation and airway hyperresponsiveness in patients with well-controlled asthma Source: Eur Respir J 2001; 18: 444-450 Year: 2001
The effect of montelukast on lung function and exhaled nitric oxide in infants with early childhood asthma Source: Eur Respir J 2005; 25: 289-294 Year: 2005
Inhaled corticosteroids and growth of airway function in asthmatic children Source: Eur Respir J 2004; 23: 861-868 Year: 2004
Effect of an inhaled alpha4-antagonist on the allergen-induced late asthmatic response in patients with mild asthma Source: Eur Respir J 2005; 26: Suppl. 49, 135s Year: 2005
Inhaled fluticasone decreases bronchial but not alveolar nitric oxide output in asthma Source: Eur Respir J 2001; 18: 635-639 Year: 2001
Effect of montelukast treatment and withdrawal on exhaled nitric oxide and lung function in atopic asthmatic children Source: Annual Congress 2007 - Anti-inflammatory therapy for childhood asthma Year: 2007
Exhaled NO and assessment of anti-inflammatory effects of inhaled steroid: dose-response relationship Source: Eur Respir J 2002; 20: 601-608 Year: 2002
Dose reduction of inhaled corticosteroids under concomitant medication with montelukast in patients with asthma Source: Eur Respir J 2002; 20: 1080-1087 Year: 2002
The effect of single dose montelukast and desloratadine, alone and in combination, on the allergen induced late airway response in atopic asthma Source: Annual Congress 2008 - New mechanisms in the pathogenesis of asthma and its response to treatment Year: 2008
Early rise in exhaled nitric oxide and mast cell activation in repeated low-dose allergen challenge Source: Eur Respir J 2006; 27: 1152-1159 Year: 2006
High levels of fractional exhaled nitric oxide (FeNO) only reflect the degree of allergen sensitization in mild childhood asthma Source: Annual Congress 2005 - Monitoring paediatric asthma Year: 2005
Are exhaled nitric oxide and airway hyperresponsiveness good predictive markers of inhaled corticosteroids dose reduction failures in children? Source: Annual Congress 2003 - Role of exhaled NO in diagnosis and therapy of childhood asthma Year: 2003
Involvement of the airway vasculature in the late asthmatic response (LAR) to allergen Source: Eur Respir J 2006; 28: Suppl. 50, 672s Year: 2006
Cough sensitivity, airway responsiveness and exhaled nitric oxide (eNO) for predicting the response to bronchodilator therapy (BDT) in patients with chronic non-productive cough Source: Annual Congress 2010 - Cough, airway hyperresponsiveness and asthma control Year: 2010